Home
Reels
Groups
Pages
See More
Groups Pages Events Blogs Offers Jobs Courses Forums Movies Games
Sign In Sign Up
Night Mode
Why Monoclonal Antibodies Lead the Oncology Biosimilars Market
Monoclonal antibodies have transformed cancer treatment by targeting specific proteins and pathways involved in tumor growth or immune regulation. As the patents of major biologic medicines expire, biosimilar versions are creating new competition in oncology. The Oncology Biosimilars Market is forecast to grow from USD 5.469 billion in 2024 to USD 14.4 billion by 2035. Monoclonal antibodies...
0 Comments ·0 Shares ·226 Views ·0 Reviews
Please log in to like, share and comment!